Delivery Order SPE2DB20D3103-SPE2DB25FL5H5

Award Date 11/1/24
Potential Completion Date 11/4/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of a pharmaceutical product, specifically dorzolamide-timolol eye drops (10 ml), with a ceiling value of $1,674.06 and a period of performance ending on May 15, 2024. The contract is a firm fixed-price delivery order awarded without a set-aside designation, indicating full and open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Dorzolamide-Timolol eye drops. The $5,035.03 firm fixed-price delivery order has an ultimate completion date of January 19, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,689.95, is for the delivery of 10 ml bottles of Dorzolamide-Timolol eye drops. The contract is a Firm Fixed Price Delivery Order with a completion date of May 31, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,075.04 firm fixed-price contract is for the delivery of Dorzolamide-Timolol eye drops, a specialty medication used to treat glaucoma. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,293.36 Delivery Order contract is for the supply of Dorzolamide-Timolol Eye Drops 10ML. The contract is a Firm Fixed Price arrangement with a period of performance through March 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is for the delivery of 10 mL bottles of Dorzolamide-Timolol eye drops to the Defense Logistics Agency (DLA). The contract, valued at $6,172.15, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 18, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,499.53, is for the supply of 10 ml bottles of the eye drop medication Dorzolamide-Timolol. The contract has an ultimate completion date of January 14, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,594.28 firm fixed-price delivery order is for the provision of 4565243277 - Dorzolamide-Timolol eye drops, 10 mL. The contract has an ultimate completion date of July 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,663.23 firm fixed-price contract is for the delivery of 4567074296 - DORZOLAMIDE-TIMOLOL EYE DROPS 10ML. The contract has an ultimate completion date of January 29, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Dorzolamide-Timolol eye drops. The Delivery Order contract, valued at $13,590.31, has a Firm Fixed Price pricing type and an ultimate completion date of October 19, 2023. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FL5H5
    Delivery Order

This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Dorzolamide-Timolol eye drops. The contract has a ceiling value of $1,046.95 and a completion date of November 4, 2024. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition.

Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The award suggests Amerisourcebergen's extensive experience and capability in supplying critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other essential medical products to federal agencies, particularly the Department of Defense.

Generated 2/27/25, 11:49 AM